ANGELA BOGNER: Open Payments
NPI 1801514617 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,188 in 71 payments from 34 companies in 2025. Trend: 2023 $2,069 · 2024 $3,244 · 2025 $2,188
Food & beverage: $2,089Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $252 |
| Novartis Pharmaceuticals Corporation | 7 | $184 |
| Daiichi Sankyo Inc. | 4 | $174 |
| Incyte Corporation | 3 | $162 |
| Regeneron Healthcare Solutions, Inc. | 2 | $152 |
| ARGENX US, INC. | 2 | $147 |
| Syndax Pharmaceuticals, Inc. | 1 | $117 |
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| Janssen Biotech, Inc. | 4 | $76 |
| Merck Sharp & Dohme LLC | 3 | $73 |
Products named: ENHERTU, LIBTAYO, Jakafi, VENCLEXTA, VYVGART, REVUFORJ, Epkinly, KISQALI.
Industry payments across OK — which companies pay providers there.
